47. Buerger disease Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 9 / Drugs : 14 - (DrugBank : 7) / Drug target genes : 5 - Drug target pathways : 16
Buerger disease and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability
| ID | Diseases (Sorted by drug repositionability) |
|---|---|
| 47 | Buerger disease |
| 13 | Multiple sclerosis/Neuromyelitis optica |
| 51 | Scleroderma |
| 84 | Sarcoidosis |
| 85 | Idiopathic interstitial pneumonia |
| 88 | Chronic thromboembolic pulmonary hypertension |
| 210 | Single Ventricle |
| 41 | Giant cell arteritis |
| 70 | Spinal stenosis |
| 86 | Pulmonary arterial hypertension |
| 2 | Amyotrophic lateral sclerosis |
| 46 | Malignant rheumatoid arthritis |
| 211 | Hypoplastic left heart syndrome |
| 212 | Tricuspid atresia |
| 317 | Trifunctional protein deficiency |